# Strata Critical Medical, Inc. (SRTA)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/strata-critical-medical-inc/ JSON: https://steadybase.io/company/strata-critical-medical-inc.json Checked Nov 10, 2026. Latest filing read: Nov 3, 2026.

## Company

- Legal name: Strata Critical Medical, Inc.
- Ticker: SRTA (Nasdaq)
- SEC CIK: 0001779128
- Industry: Transportation Services (SIC 4700)
- Headquarters: New York, NY
- Fiscal year ends: December 31
- SEC filer category: Accelerated filer
- Website: stratacritical.com
- LinkedIn: https://www.linkedin.com/company/strata-critical
- Next earnings date: Nov 9, 2026

## Key facts

- Revenue: $197.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026013628/0001628280-26-013628-index.html
- Operating income: -$22.4M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026013628/0001628280-26-013628-index.html
- Net income: $41.3M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026013628/0001628280-26-013628-index.html
- SG&A: $60.9M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026013628/0001628280-26-013628-index.html
- Employees: 601 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026013628/blde-20251231.htm
- Shares outstanding: 89,319,857 as of Oct 26, 2026 (10-Q filed Nov 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026069265/0001628280-26-069265-index.html
- Auditor: Deloitte & Touche LLP, New York, New York, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026013628/blde-20251231.htm

## Business

(f/k/a Blade Air Mobility, Inc.) (“Strata” or the “Company”) is a time-critical logistics and medical services provider to the United States healthcare industry. The Company operates one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1779128/000162828026013628/blde-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $197.1M | -$22.4M | $41.3M | $60.9M |
| Dec 31, 2024 | $146.8M | -$22.5M | -$27.3M | $50.9M |
| Dec 31, 2023 | $225.2M | -$68.1M | -$56.1M | $105.6M |
| Dec 31, 2022 | $146.1M | -$53.5M | -$27.3M | $70.3M |
| Sep 30, 2021 | $50.5M | -$24.1M | -$40.1M | $32.9M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/strata-critical-medical-inc.json

## Officers and directors

- Will Heyburn, Co-CEO and CFO. Source: 8-K filed Nov 3, 2026, https://www.sec.gov/Archives/edgar/data/1779128/000162828026069117/srta-earningreleasexq32026.htm
- Melissa M. Tomkiel, Co-CEO and General Counsel. Source: Form 4 filed Sep 25, 2026, https://www.sec.gov/Archives/edgar/data/1779128/000162828026063577/0001628280-26-063577-index.htm
- William A. Heyburn, Co-CEO and CFO. Source: Form 4 filed Sep 25, 2026, https://www.sec.gov/Archives/edgar/data/1779128/000162828026063576/0001628280-26-063576-index.htm
- Amir Cohen, Chief Accounting Officer. Source: Form 4 filed Sep 10, 2026, https://www.sec.gov/Archives/edgar/data/1779128/000162828026061364/0001628280-26-061364-index.htm
- Louis R. Verdetto, CEO, Clinical Services. Source: Form 4 filed Sep 10, 2026, https://www.sec.gov/Archives/edgar/data/1779128/000162828026061370/0001628280-26-061370-index.htm
- Scott M. Wunsch, CEO, Logistics. Source: Form 4 filed Sep 10, 2026, https://www.sec.gov/Archives/edgar/data/1779128/000162828026061368/0001628280-26-061368-index.htm
- Amir M. Cohen, Chief Accounting Officer. Source: 10-K filed Mar 3, 2026, https://www.sec.gov/Archives/edgar/data/1779128/000162828026013628/blde-20251231.htm
- Andrew C. Lauck, Board member (per proxy). Source: DEF 14A filed Apr 14, 2026, https://www.sec.gov/Archives/edgar/data/1779128/000114036126014530/ny20060135x1_def14a.htm
- Andrew Lauck, Board member (per proxy). Source: DEF 14A filed Apr 14, 2026, https://www.sec.gov/Archives/edgar/data/1779128/000114036126014530/ny20060135x1_def14a.htm
- Robert S. Wiesenthal, Board member (per proxy). Source: DEF 14A filed Apr 14, 2026, https://www.sec.gov/Archives/edgar/data/1779128/000114036126014530/ny20060135x1_def14a.htm

## Recent 8-K events

- Nov 3, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026069117/srta-20261103.htm
- Aug 4, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026052152/srta-20260804.htm
- Jun 3, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026040342/blde-20260528.htm
- May 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026030898/srta-20260506.htm
- Mar 3, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026013553/srta-20260303.htm
- Feb 5, 2026: Item 1.01, Entry into a material definitive agreement; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1779128/000110465926010689/tm265039d1_8k.htm
- Dec 3, 2025: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1779128/000110465925118180/tm2532670d1_8k.htm
- Nov 10, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828025050785/srta-20251110.htm
- Sep 16, 2025: Item 1.01, Entry into a material definitive agreement; Item 2.01, Completion of acquisition or disposition of assets; Item 3.02, Unregistered sales of equity securities; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1779128/000177912825000114/srta-20250916.htm
- Aug 29, 2025: Item 1.01, Entry into a material definitive agreement; Item 2.01, Completion of acquisition or disposition of assets; Item 5.02, Departure or appointment of directors or officers; compensation; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 7.01, Regulation FD disclosure; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1779128/000110465925085185/tm2524340d2_8k.htm

## Insider trades (Form 4)

- Nov 5, 2026: Andrew Lauck (Director) bought 2,000 shares, about $9,998. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026071913/0001628280-26-071913-index.htm
- Aug 10, 2026: Reginald Love (Director) sold 5,091 shares, about $29,273. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026056841/0001628280-26-056841-index.htm
- Jun 8, 2026: William A. Heyburn (Co-CEO and CFO) sold 31,671 shares, about $185,909. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026042183/0001628280-26-042183-index.htm
- Jun 8, 2026: Amir Cohen (Chief Accounting Officer) sold 4,655 shares, about $27,325. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026042182/0001628280-26-042182-index.htm
- Jun 8, 2026: Melissa M. Tomkiel (Co-CEO and General Counsel) sold 29,730 shares, about $174,515. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026042180/0001628280-26-042180-index.htm
- Jun 8, 2026: Scott M. Wunsch (CEO, Logistics) sold 5,550 shares, about $32,579. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026042177/0001628280-26-042177-index.htm
- May 22, 2026: Amir Cohen (Chief Accounting Officer) sold 50,875 shares, about $299,435. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026038171/0001628280-26-038171-index.htm
- May 11, 2026: Amir Cohen (Chief Accounting Officer) sold 14,306 shares, about $82,832. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026034586/0001628280-26-034586-index.htm
- Dec 9, 2025: William A. Heyburn (Co-CEO and CFO) bought 17,000 shares, about $75,990. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828025056310/0001628280-25-056310-index.htm
- Dec 5, 2025: Andrew Lauck (Director) bought 5,000 shares, about $21,850. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828025055610/0001628280-25-055610-index.htm
- Nov 20, 2025: Reginald Love (Director) sold 11,000 shares, about $48,070. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828025053810/0001628280-25-053810-index.htm
- Nov 19, 2025: Reginald Love (Director) sold 11,000 shares, about $47,410. Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828025053386/0001628280-25-053386-index.htm
- Aug 4, 2025: Melissa M. Tomkiel (President and General Counsel) sold 47,995 shares, about $237,095. Source: https://www.sec.gov/Archives/edgar/data/1779128/000177912825000077/0001779128-25-000077-index.htm
- Aug 4, 2025: William A. Heyburn (Chief Financial Officer) sold 46,918 shares, about $231,775. Source: https://www.sec.gov/Archives/edgar/data/1779128/000177912825000075/0001779128-25-000075-index.htm

## What management said

- "Given Strata's improved cash generation coupled with the receipt of our first passenger sale earn-out, we are now in a position to both accelerate our target pace of acquisitions as well as opportunistically return cash to shareholders through our new buyback program" Will Heyburn, Co-CEO and CFO (8-K filed Nov 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/1779128/000162828026069117/srta-earningreleasexq32026.htm

## Latest filings

- 8-K filed Nov 3, 2026: https://www.sec.gov/Archives/edgar/data/1779128/000162828026069117/srta-20261103.htm
- 10-K filed Mar 3, 2026: https://www.sec.gov/Archives/edgar/data/1779128/000162828026013628/blde-20251231.htm
- 10-Q filed Nov 3, 2026: https://www.sec.gov/Archives/edgar/data/1779128/000162828026069265/srta-20260930.htm
- DEF 14A filed Apr 14, 2026: https://www.sec.gov/Archives/edgar/data/1779128/000114036126014530/ny20060135x1_def14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/